Clinical Trials Logo

Clinical Trial Summary

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.


Clinical Trial Description

The study is based on results form 2 previous studies carried out by the GFAOP. This study aims to evaluate the capacity of units to follow the recommendations in the protocol. It will look mainly at treatment compliance and outcome for the children treated. The study will also evaluate the improvement in treatment compliance and reporting. This work will help the group to evaluate future needs in participating units and help us adapt treatment programmes to local conditions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04423484
Study type Observational
Source French Africa Pediatric Oncology Group
Contact BRENDA Ms MALLON, MSC
Phone 0033142115411
Email brenda.mallon@gustaveroussy.fr
Status Recruiting
Phase
Start date July 1, 2020
Completion date September 30, 2026

See also
  Status Clinical Trial Phase
Completed NCT00001509 - A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor Phase 2
Not yet recruiting NCT04168788 - Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL N/A
Completed NCT05245123 - Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families
Recruiting NCT05985161 - A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors Phase 2